Interv Akut Kardiol. 2005;4(2):115-118
Acute pulmonary embolism is the third most common cardiovascular disease with very high mortality. The prognosis of acute pulmonary embolism is dependent on the degree of haemodynamic status of the patients. Risk factors include right ventricular dysfunction, elevated plasma levels of cardiac troponins and brain natriuretic peptide. Based on these factors we can identify a group of patients with higher recurrence rates of embolism and with higher mortality. According to some authors, the thrombolytic treatment in this group of patients is more effective than conventional heparin treatment, although there is no clear evidence and the approach must be individual. There use of thrombolytic treatment in a group of high risk patients with acute submassive pulmonary embolism is well documented.
Published: January 1, 2006 Show citation